Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Bioengineering
Reference42 articles.
1. Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., et al. (1969). Adriamycin, 14-hydroxydaunomycin: a new antitumor antibiotic from S. peucetius var. Caesius. Biotechnology and Bioengineering, 11, 1101–1110.
2. Cortes-Funes, H., & Coronado, C. (2007). Role of anthracyclines in the era of targeted therapy. Cardiovascular Toxicology, 7, 56–60.
3. Weiss, R. B. (1992). The anthracyclines: will we ever find a better doxorubicin. Seminars in Oncology, 19, 670–686.
4. Carvalho, C., Santos, R. X., Cardoso, S., Correia, S., Oliveira, P. J., Santos, M. S., et al. (2009). Doxorubicin: the good, the bad and the ugly effect. Current Medicinal Chemistry, 16, 3267–3285.
5. Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003). Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer, 97, 2869–2879.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献